Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Clover Using GE FlexFactory for China Biologic Manufacturing Plant

publication date: Jan 25, 2018

Chengdu's Clover Biopharma announced plans to build a biologic drug manufacturing facility in Changxing, Zhejiang Province. The facility, which will have two 2000-L bioreactors, will be built around GE Healthcare’s FlexFactory single-use technology. Clover will use the plant for its biological fusion protein products, including both innovative drugs and biosimilars. Last month, Clover received CFDA permission to begin China trials of its Enbrel biosimilar for rheumatoid arthritis. The company also raised $9.5 million in a Series A funding recently. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China